Cue Biopharma Inc.

Cue Biopharma, a Boston‑based clinical‑stage biotech, advances injectable therapies that selectively modulate T cells—CUE‑101 (HPV+ HNSCC), CUE‑102 (WT1+ cancers), and preclinical CUE‑401 for Treg induction. Partnerships with LG Chem, Ono, and Einstein underpin the pipeline.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 41
HQ: Boston

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
CUE	Cue Biopharma Inc. Cap: 0.0B	EQUITY	NMS	USD	US22978P1066	Active	📈